Evaluation of miR18a-5p, miR22-3p, miR24-3p, miR106b-5p, miR107, miR125b-5p and miR155a-5p levels in child and adolescent patients with attention deficit hyperactivity disorder
( Psychiatry and Clinical Psychopharmacology 2014; 24: S87-S88)
( Psychiatry and Clinical Psychopharmacology 2014; 24: S87-S88)
Efruz Pirdoğan Aydın, Hani Alsaadoni, Azra Gökovalı Beğenen, Ömer Akil Özer, Kayıhan Oğuz Karamustafalıoğlu, Sadrettin Pençe
( Psychiatry and Clinical Psychopharmacology 2022; 32: 98-106) DOI: 10.5152/pcp.2022.22391